Shares of bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) rose 38.5% during mid-day trading on Friday . The company traded as high as $0.18 and last traded at $0.18. Approximately 9 shares changed hands during trading, a decline of 100% from the average daily volume of 8,515 shares. The stock had previously closed at $0.13.
bioAffinity Technologies Trading Up 38.5%
The stock’s fifty day simple moving average is $0.18 and its 200-day simple moving average is $0.39.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Recommended Stories
- Five stocks we like better than bioAffinity Technologies
- Why Invest in High-Yield Dividend Stocks?
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Trades Members of Congress Are Making Right Now
- Growth Stocks: What They Are, Examples and How to Invest
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
